Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury

M. Matejovic, L. Valesova, J. Benes, R. Sykora, R. Hrstka, J. Chvojka,

. 2017 ; 18 (1) : 183. [pub] 20170531

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010526

BACKGROUND: Septic acute kidney injury affects 40-50% of all septic patients. Molecular differences between septic patients with and without acute kidney injury (AKI) are only poorly understood. Here, we investigated gene expression changes that differentiated the subjects who developed septic AKI from those who did not and coupled this approach with traditional parameters of renal physiology. METHODS: In 15 anesthetized, mechanically ventilated and instrumented pigs, progressive sepsis was induced either by peritonitis or by continuous intravenous infusion of Pseudomonas aeruginosa. Animals received standard intensive care including goal-directed hemodynamic management. Analyses were performed on kidneys from sham operated animals, septic pigs without AKI, and pigs with septic AKI. Before, and at 12, 18 and 22 h of progressive sepsis, systemic and renal hemodynamics, cortex microcirculation and plasma IL-6 and TNF-α were measured. At 22 h whole kidney expression of pre-selected genes was analyzed by quantitative Real Time PCR. RESULTS: Animals with septic AKI had systemic hemodynamic phenotype (normo- or hyperdynamic) comparable with non-AKI subjects, but demonstrated higher plasma levels of cytokines, an increase in renal vascular resistance and early fall in cortical microcirculatory blood flow. The genes whose expression discriminated septic AKI from non-AKI included Toll like receptor 4 (up-regulated 2.7-fold, P = 0.04); Cyclooxygenase-2 (up-regulated 14.6-fold, P = 0.01), Angiotensin II Receptor (up-regulated 8.1-fold, P = 0.01), Caspase 3 (up-regulated 5.1-fold, P = 0.02), Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha (down-regulated 2-fold, P = 0.02). CONCLUSIONS: In this preliminary experimental study, kidney gene expression was profoundly different in animals that developed septic AKI as opposed to septic animals that did not. The biological functions of the genes differentially expressed support a role of inflammatory overstimulation coupled with metabolic and apoptotic molecular responses in early septic AKI. Cyclooxygenase-2 and angiotensin type 2 receptor-dependent downstream mechanisms appear fruitful targets for future mechanistic research.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010526
003      
CZ-PrNML
005      
20180418095658.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12882-017-0602-x $2 doi
035    __
$a (PubMed)28569136
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Matejovic, Martin $u 1st Medical Department, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic. matejovic@fnplzen.cz. Experimental Intensive Care Unit, Biomedical Centre, Faculty of Medicine in Plzen, Charles University, alej Svobody 1655/76, Plzen, Czech Republic. matejovic@fnplzen.cz. 1st Medical Department, Teaching Hospital, alej Svobody 80, 304 60, Plzen, Czech Republic. matejovic@fnplzen.cz.
245    10
$a Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury / $c M. Matejovic, L. Valesova, J. Benes, R. Sykora, R. Hrstka, J. Chvojka,
520    9_
$a BACKGROUND: Septic acute kidney injury affects 40-50% of all septic patients. Molecular differences between septic patients with and without acute kidney injury (AKI) are only poorly understood. Here, we investigated gene expression changes that differentiated the subjects who developed septic AKI from those who did not and coupled this approach with traditional parameters of renal physiology. METHODS: In 15 anesthetized, mechanically ventilated and instrumented pigs, progressive sepsis was induced either by peritonitis or by continuous intravenous infusion of Pseudomonas aeruginosa. Animals received standard intensive care including goal-directed hemodynamic management. Analyses were performed on kidneys from sham operated animals, septic pigs without AKI, and pigs with septic AKI. Before, and at 12, 18 and 22 h of progressive sepsis, systemic and renal hemodynamics, cortex microcirculation and plasma IL-6 and TNF-α were measured. At 22 h whole kidney expression of pre-selected genes was analyzed by quantitative Real Time PCR. RESULTS: Animals with septic AKI had systemic hemodynamic phenotype (normo- or hyperdynamic) comparable with non-AKI subjects, but demonstrated higher plasma levels of cytokines, an increase in renal vascular resistance and early fall in cortical microcirculatory blood flow. The genes whose expression discriminated septic AKI from non-AKI included Toll like receptor 4 (up-regulated 2.7-fold, P = 0.04); Cyclooxygenase-2 (up-regulated 14.6-fold, P = 0.01), Angiotensin II Receptor (up-regulated 8.1-fold, P = 0.01), Caspase 3 (up-regulated 5.1-fold, P = 0.02), Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Alpha (down-regulated 2-fold, P = 0.02). CONCLUSIONS: In this preliminary experimental study, kidney gene expression was profoundly different in animals that developed septic AKI as opposed to septic animals that did not. The biological functions of the genes differentially expressed support a role of inflammatory overstimulation coupled with metabolic and apoptotic molecular responses in early septic AKI. Cyclooxygenase-2 and angiotensin type 2 receptor-dependent downstream mechanisms appear fruitful targets for future mechanistic research.
650    _2
$a akutní poškození ledvin $x genetika $x mikrobiologie $x patofyziologie $7 D058186
650    _2
$a zvířata $7 D000818
650    _2
$a kaspasa 3 $x genetika $7 D053148
650    _2
$a cyklooxygenasa 2 $x genetika $7 D051546
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a exprese genu $7 D015870
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a hemodynamika $7 D006439
650    _2
$a interleukin-6 $x krev $7 D015850
650    _2
$a PPARGC1A $x genetika $7 D000071248
650    _2
$a receptory angiotensinu $x genetika $7 D011945
650    _2
$a sepse $x komplikace $x patofyziologie $7 D018805
650    _2
$a prasata $7 D013552
650    _2
$a toll-like receptor 4 $x genetika $7 D051197
650    _2
$a TNF-alfa $x krev $7 D014409
655    _2
$a časopisecké články $7 D016428
700    1_
$a Valesova, Lenka $u 1st Medical Department, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic. Experimental Intensive Care Unit, Biomedical Centre, Faculty of Medicine in Plzen, Charles University, alej Svobody 1655/76, Plzen, Czech Republic.
700    1_
$a Benes, Jan $u Experimental Intensive Care Unit, Biomedical Centre, Faculty of Medicine in Plzen, Charles University, alej Svobody 1655/76, Plzen, Czech Republic. Department of Anesthesia and Intensive Care Medicine, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
700    1_
$a Sykora, Roman $u 1st Medical Department, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
700    1_
$a Hrstka, Roman $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, Czech Republic.
700    1_
$a Chvojka, Jiri $u 1st Medical Department, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic. Experimental Intensive Care Unit, Biomedical Centre, Faculty of Medicine in Plzen, Charles University, alej Svobody 1655/76, Plzen, Czech Republic.
773    0_
$w MED00008194 $t BMC nephrology $x 1471-2369 $g Roč. 18, č. 1 (2017), s. 183
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28569136 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180418095758 $b ABA008
999    __
$a ok $b bmc $g 1288011 $s 1007338
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 18 $c 1 $d 183 $e 20170531 $i 1471-2369 $m BMC nephrology $n BMC Nephrol $x MED00008194
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options